The life science industry covers various areas such as healthcare, pharmaceuticals, food and agriculture. Reagents form a vital element of all the biotechnological applications and related processes. Biotechnology (life science and analytical) reagents are the substances or compounds used to detect or synthesize another substance in order to provide a test reading. Life science reagents include comprehensive range of kits and reagents for life science use, in nucleic acid isolation as well as enzymes, reagents and additives. These reagents are used in the field of research, diagnosis, bioscience, and education.
The global life science reagents market report estimates the market size (Revenue US$ million – 2014 to 2021) and composition of this market in terms of reagent types (PCR reagent kits, cell and tissue culture reagents, flow cytometry reagents, electrophoresis reagents, chromatography reagents, in vitro diagnostic reagents, etc.), end users (commercial and contract manufacturers, research and academic institutions, clinical laboratories, forensic laboratories) and forecasts growth trends (CAGR% – 2017 to 2021).
The global life science reagents market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global life science reagents market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global life science reagents market and included in this report are Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories, Inc., Lonza Group Ltd., Promega Corporation, Sigma Aldrich Corporation, Merck Millipore, Siemens Healthcare, and Waters Corporation.